|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$80,778.46 |
2.37% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$80,469.65 |
2.36% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$79,309.61 |
2.33% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$79,256.10 |
2.33% |
| Steris Plc |
STE |
G8473T100 |
298 |
$78,767.36 |
2.31% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$76,434.84 |
2.24% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$75,874.44 |
2.23% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$75,604.48 |
2.22% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$75,407.36 |
2.21% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$74,367.78 |
2.18% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$74,104.78 |
2.18% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$73,410.95 |
2.16% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$73,677.05 |
2.16% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$73,676.40 |
2.16% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$73,172.95 |
2.15% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$73,228.14 |
2.15% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$72,873.50 |
2.14% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$72,123.04 |
2.12% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$71,526.84 |
2.10% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$71,295.31 |
2.09% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$70,731.62 |
2.08% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$70,771.08 |
2.08% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$70,275.92 |
2.06% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$69,669.84 |
2.05% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,532.53 |
2.01% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$67,979.15 |
2.00% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$67,802.87 |
1.99% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$67,808.82 |
1.99% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$67,921.34 |
1.99% |
| Waters Corporation |
WAT |
941848103 |
147 |
$67,656.75 |
1.99% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$66,982.09 |
1.97% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$66,990.03 |
1.97% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$66,376.98 |
1.95% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$66,589.34 |
1.95% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$65,937.24 |
1.94% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$65,235.00 |
1.92% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$64,601.77 |
1.90% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$64,113.00 |
1.88% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$64,076.00 |
1.88% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,182.00 |
1.88% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$64,071.85 |
1.88% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$63,330.80 |
1.86% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$63,499.79 |
1.86% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$62,083.97 |
1.82% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$61,823.98 |
1.81% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$58,994.60 |
1.73% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$58,047.29 |
1.70% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$56,019.26 |
1.64% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,541.74 |
1.31% |
| US Dollar |
$USD |
|
22,804 |
$22,803.98 |
0.67% |
| Japanese Yen |
$JPY |
|
237,600 |
$1,487.60 |
0.04% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|